Shopping Cart 0
Cart Subtotal
USD 0

Global Ventricular Assist Devices Market

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 2750

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 3500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 4500
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Global Ventricular Assist Devices Market 2019-2025

[84 pages report] This market research report includes a detailed segmentation of the global ventricular assist devices market-By Product (Left Ventricular Assist Devices [LVAD], Right Ventricular Assist Devices [RVAD], and Biventricular Assist Devices [BIVAD]), By Design (Transcutaneous Ventricular Assist Devices and Implantable Ventricular Assist Devices), By Application (Bridge-to-Transplant [BTT] Therapy, Destination Therapy, Bridge-to-Recovery [BTR] Therapy, and Bridge-to-Candidacy [BTC] Therapy), and By Region (North America, Europe, Asia Pacific and Rest of the World)

Overview of the Global Ventricular Assist Devices Market Research

Infoholic's market research report predicts that the global ventricular assist devices market will grow at a CAGR of 13.8% during the forecast period. The market has witnessed steady growth in the past few years and development in technology with the introduction of innovative products have increased the acceptance of heart assist devices in the market. The market is fueled by increase in the incidence of heart failure, lack of heart donors for transplantation, and increasing elderly population.

 

 

The market continues to grow and is one of the most widely used devices for the functioning of heart in cardiac failure and weakened heart patients. The market is getting revolutionized with the advancement in technology. Vendors are focusing towards new product launches, product approvals, and targeting towards end-user's perspective. The market generates the revenue from the key players operating in this field and some of vendors are Medtronic plc, Reliant Heart Inc., Abbott Laboratories, Berlin Heart GmbH, Jarvik Heart, Inc., and ABIOMED, Inc.

According to Infoholic Research analysis, North America accounted for the largest share of the global ventricular assist devices market in 2018 and will retain high position during the forecast period. According to American Heart Association, an estimated 92.1 million population in the US have at least one type of CVD and by 2030 it is projected that 43.9% of the US adult population to have some form of CVD. Favorable reimbursement policies, availability of advanced technologies, and growing cardiovascular diseases will increase the adoption and demand of the devices in this region. The Asia Pacific is expected to grow during the forecast period, owing to factors such as high prevalence of cardiovascular diseases, increasing healthcare expenditure, and presence of huge population base.

By Product:

Left Ventricular Assist Devices (LVAD)

Right Ventricular Assist Devices (RVAD)

Biventricular Assist Devices (BIVAD)

In 2018, the left ventricular assist devices segment occupied the largest share and is expected to grow at high CAGR during the forecast period. Increasing number of patients suffering from last-stage heart failure, advancement in technology such as effectiveness, high survival rate, and decreased risk of the devices makes the segment the most common among other VAD devices.

By Design:

Transcutaneous Ventricular Assist Devices

Implantable Ventricular Assist Devices

In 2018, the implantable ventricular assist devices segment occupied the largest share and is expected to grow at high CAGR during the forecast period.

By Application:

Bridge-to-Transplant (BTT) Therapy

Destination Therapy

Bridge-to-Recovery (BTR) Therapy

Bridge-to-Candidacy (BTC) Therapy

By application, the bridge-to-recovery (BTR) therapy generated the maximum revenue, thus accounting for more than 35% of the global ventricular assist devices market in 2018 and the segment is expected to grow at high CAGR during the forecast period. The destination therapy segment is expected to be the second highest growing segment during the forecast period.

By Regions:

North America

Europe

APAC

ROW

The market is dominated by North America, followed by Europe and Asia Pacific. US occupied the major share of the North American market due to the increasing disease prevalence and availability of advanced technologies.

Ventricular Assist Devices Market Research Competitive Analysis-The global ventricular assist devices market has massive growth opportunities in both developed and developing regions. The advancement and upgradation of devices will increase the competition among vendors. Many vendors are focusing on product approvals and developing innovative products to strengthen their product portfolio that intensifies the market competition. In October 2018, FDA approved HeartMate 3 left ventricular assist device developed by Abbott, as a destination therapy for patients with advanced heart failure. The approval device supported by the Momentum 3 trial showed a survival rate of 82.8% at two years with rates of suspected pump thrombosis at only 1.1%. Health Canada issued a Class IV License with conditions to HeartMate 3 left ventricular assist system developed by Thoratec Corporation in 2018. In 2018, Calon Cardio-Technology has launched a clinical trial of the UK's first artificial heart pump. In addition, other leading players are focusing in huge investments on research and development activities to develop new products to attain maximum share in the market.

Key vendors:

Medtronic plc

Abbott Laboratories

ReliantHeart Inc.

Berlin Heart GmbH

Jarvik Heart, Inc.

ABIOMED, Inc.

BiVACOR

Calon Cardio-Technology Ltd.

LivaNova PLC

Evaheart Medical USA, Inc. (Asahi Kasei Corp.)

Fresenius Medical Care AG & Co. KGaA (XENIOS AG)

Maquet GmbH (Getinge AB)

Key competitive facts -

The market is highly competitive with all the players competing to gain market shares. Intense competition, rapid advancements in technology, frequent changes in government policies, and the prices are key factors that confront the market.

The requirement of high initial investment, implementation, and maintenance cost in the market are also limiting the entry of new players.

Benefits-The report provides complete details about the usage and adoption rate of ventricular assist devices. Thus, the key stakeholders can know about the major trends, drivers, investments, vertical player's initiatives, and government initiatives towards the medical devices segment in the upcoming years along with details of the pureplay companies entering the market. Moreover, the report provides details about the major challenges that are going to impact the market growth. Additionally, the report gives complete details about the key business opportunities to key stakeholders in order to expand their business and capture the revenue in specific verticals, and to analyze before investing or expanding the business in this market.

Key Takeaways:

Understanding the potential market opportunity with precise market size and forecast data

Detailed market analysis focusing on the growth of ventricular assist devices industry

Factors influencing the growth of ventricular assist devices market

In-depth competitive analysis of dominant and pureplay vendors

Prediction analysis of ventricular assist devices industry in both developed and developing regions

Key insights related to major segments of the ventricular assist devices market

Latest market trend analysis impacting the buying behavior of the consumers

 

Key Stakeholders -

 

 

READ MORE

Table Of Content

Scope

Table of Contents

1 INDUSTRY OUTLOOK 8

1.1 Industry Overview 8

1.1.1 Geography 8

1.1.2 Medical Technologies 8

1.1.3 Industry Trends 10

1.2 Total Addressable Market 11

2 Report Outline 12

2.1 Report Scope 12

2.2 Report Summary 12

2.3 Research Methodology 13

2.4 Report Assumptions 14

3 Market Snapshot 15

3.1 Market Definition-Infoholic Research 15

3.2 Device Benefits 15

3.3 Segmented Addressable Market (SAM) 15

3.4 Trends in the Ventricular Assist Devices Market 16

3.5 Related Markets 17

3.5.1 Stents 17

3.5.2 Interventional Cardiology 17

3.5.3 Angioplasty 17

4 Market Outlook 18

4.1 Regulatory Status 18

4.2 Reimbursement 19

4.3 Market Segmentation 21

4.4 PEST Analysis 21

4.5 Porter 5(Five) Forces 23

5 Market Characteristics 24

5.1 DRO-Global Ventricular Assist Devices Market Dynamics 24

5.1.1 Drivers 25

5.1.1.1 Upsurge in the incidence of cardiovascular disease (CVD) 25

5.1.1.2 Growing geriatric population 25

5.1.1.3 Dearth of heart donors across the globe 26

5.1.2 Opportunities 26

5.1.2.1 Increased approvals, fun ding, and pipeline products 26

5.1.2.2 Upsurge in healthcare spending and demand for better treatment in emerging economies 27

5.1.3 Restraints 27

5.1.3.1 High cost of the devices 27

5.1.3.2 Strict regulatory policies 27

5.2 DRO-Impact Analysis 28

5.3 Key Stakeholders 29

6 Product: Market Size and Analysis 30

6.1 Overview 30

6.2 Left Ventricular Assist Devices 31

6.3 Right Ventricular Assist Devices 32

6.4 Biventricular Assist Devices 33

7 Design: Market Size and Analysis 35

7.1 Overview 35

7.2 Transcutaneous Ventricular Assist Devices 36

7.3 Implantable Ventricular Assist Devices 36

8 Applications: Market Size and Analysis 37

8.1 Overview 37

8.2 Bridge-to-Transplant (BTT) Therapy 38

8.3 Destination Therapy 39

8.4 Bridge-to-Recovery (BTR) Therapy 40

8.5 Bridge-to-Candidacy (BTC) Therapy 41

9 Regions: Market Size and Analysis 43

9.1 Overview 43

9.2 North America 44

9.3 Europe 46

9.4 Asia Pacific 47

9.5 Rest of the World 49

10 Competitive Landscape 51

10.1 Overview 51

11 Vendor Profiles 53

11.1 Medtronic plc 53

11.1.1 Overview 53

11.1.2 Business Units 58

11.1.3 Geographic Presence 59

11.1.4 Business Focus 59

11.1.5 SWOT Analysis 60

11.1.6 Business Strategies 60

11.2 Abbott Laboratories 61

11.2.1 Overview 61

11.2.2 Business Units 64

11.2.3 Geographic Presence 65

11.2.4 Business Focus 65

11.2.5 SWOT Analysis 66

11.2.6 Business Strategies 66

11.3 Reliant Heart Inc. 67

11.3.1 Overview 67

11.3.2 Business Focus 68

11.3.3 SWOT Analysis 68

11.3.4 Business Strategies 68

11.4 Jarvik Heart, Inc. 69

11.4.1 Overview 69

11.4.2 Business Focus 70

11.4.3 SWOT Analysis 70

11.4.4 Business Strategies 71

11.5 Berlin Heart GmbH 71

11.5.1 Overview 71

11.5.2 Business Focus 72

11.5.3 SWOT Analysis 72

11.5.4 Business Strategies 73

12 Companies to Watch For 74

12.1 BiVACOR 74

12.1.1 Overview 74

12.2 ABIOMED, Inc. 74

12.2.1 Overview 74

12.2.2 ABIOMED, Inc.: Recent Developments 75

12.3 Calon Cardio-Technology Ltd. 76

12.3.1 Overview 76

12.3.2 Calon Cardio-Technology Ltd.: Recent Developments 77

12.4 Maquet GmbH (Getinge AB) 77

12.4.1 Overview 77

12.4.2 Maquet GmbH (Getinge AB): Recent Developments 78

12.5 LivaNova PLC 79

12.5.1 Overview 79

12.5.2 LivaNova PLC: Recent Developments 79

12.6 Evaheart Medical USA, Inc. (Asahi Kasei Corp.) 80

12.6.1 Overview 80

12.6.2 Evaheart Medical USA, Inc.: Recent Developments 80

12.7 Fresenius Medical Care AG & Co. KGaA (XENIOS AG) 81

12.7.1 Overview 81

12.7.2 Fresenius Medical Care AG & Co. KGaA (XENIOS AG): Recent Developments 81

13 Annexure 83

13.1 Abbreviations 83

 


List Of Figure

Charts

CHART 1 GLOBAL MEDICAL DEVICES MARKET SEGMENTATION 9

CHART 2 RESEARCH METHODOLOGY OF GLOBAL VENTRICULAR ASSIST DEVICES MARKET 14

CHART 3 GLOBAL VENTRICULAR ASSIST DEVICES MARKET REVENUE, 2018-2025 (USD MILLION) 17

CHART 4 SEGMENTATION OF GLOBAL VENTRICULAR ASSIST DEVICES MARKET 22

CHART 5 PEST ANALYSIS OF GLOBAL VENTRICULAR ASSIST DEVICES MARKET 22

CHART 6 PORTER 5 FORCES ON GLOBAL VENTRICULAR ASSIST DEVICES MARKET 24

CHART 7 MARKET DYNAMICS-DRO ANALYSIS 25

CHART 8 DRO-IMPACT ANALYSIS OF GLOBAL VENTRICULAR ASSIST DEVICES MARKET 29

CHART 9 KEY STAKEHOLDERS OF THE GLOBAL VENTRICULAR ASSIST DEVICES MARKET 30

CHART 10 GLOBAL VENTRICULAR ASSIST DEVICES MARKET BY PRODUCT SEGMENTATION, 2018 (%) 31

CHART 11 GLOBAL VENTRICULAR ASSIST DEVICES MARKET BY TECHNOLOGY SEGMENTATION, 2025 (%) 32

CHART 12 GLOBAL LEFT VENTRICULAR ASSIST DEVICES MARKET FORECAST, 2018-2025 (USD MILLION) 33

CHART 13 GLOBAL RIGHT VENTRICULAR ASSIST DEVICES MARKET FORECAST, 2018-2025 (USD MILLION) 34

CHART 14 GLOBAL BIVENTRICULAR ASSIST DEVICES MARKET FORECAST, 2018-2025 (USD MILLION) 35

CHART 15 GLOBAL VENTRICULAR ASSIST DEVICES MARKET BY DESIGN SEGMENTATION, 2018 (%) 36

CHART 16 GLOBAL VENTRICULAR ASSIST DEVICES MARKET BY APPLICATION SEGMENTATION, 2018 (%) 38

CHART 17 GLOBAL VENTRICULAR ASSIST DEVICES MARKET BY APPLICATION SEGMENTATION, 2025 (%) 39

CHART 18 GLOBAL BRIDGE-TO-TRANSPLANT (BTT) THERAPY MARKET FORECAST, 2018-2025 (USD MILLION) 39

CHART 19 GLOBAL DESTINATION THERAPY MARKET FORECAST, 2018-2025 (USD MILLION) 40

CHART 20 GLOBAL BRIDGE-TO-RECOVERY (BTR) THERAPY MARKET FORECAST, 2018-2025 (USD MILLION) 41

CHART 21 GLOBAL BRIDGE-TO-CANDIDACY (BTC) THERAPY MARKET FORECAST, 2018-2025 (USD MILLION) 42

CHART 22 GLOBAL VENTRICULAR ASSIST DEVICES MARKET BY GEOGRAPHICAL SEGMENTATION, 2018 (%) 44

CHART 23 GLOBAL VENTRICULAR ASSIST DEVICES MARKET BY GEOGRAPHICAL SEGMENTATION, 2025 (%) 45

CHART 24 VENTRICULAR ASSIST DEVICES MARKET REVENUE IN NORTH AMERICA, 2018-2025 (USD MILLION) 46

CHART 25 VENTRICULAR ASSIST DEVICES MARKET REVENUE IN EUROPE, 2018-2025 (USD MILLION) 48

CHART 26 VENTRICULAR ASSIST DEVICES MARKET REVENUE IN ASIA PACIFIC, 2018-2025 (USD MILLION) 49

CHART 27 VENTRICULAR ASSIST DEVICES MARKET REVENUE IN REST OF THE WORLD, 2018-2025 (USD MILLION) 51

CHART 28 MEDTRONIC PLC: OVERVIEW SNAPSHOT 57

CHART 29 MEDTRONIC PLC: BUSINESS UNITS 59

CHART 30 MEDTRONIC PLC: GEOGRAPHIC PRESENCE 60

CHART 31 MEDTRONIC PLC: SWOT ANALYSIS 61

CHART 32 ABBOTT LABORATORIES: OVERVIEW SNAPSHOT 64

CHART 33 ABBOTT LABORATORIES: BUSINESS UNITS 65

CHART 34 ABBOTT LABORATORIES: GEOGRAPHIC PRESENCE 66

CHART 35 ABBOTT LABORATORIES: SWOT ANALYSIS 67

CHART 36 RELIANTHEART INC.: SWOT ANALYSIS 69

CHART 37 JARVIK HEART, INC.: SWOT ANALYSIS 71

CHART 38 BERLIN HEART GMBH: SWOT ANALYSIS 73

 

 

 


List Of Table

TABLE 1 REGULATORY STATUS OF GLOBAL VENTRICULAR ASSIST DEVICES MARKET 19

TABLE 2 GLOBAL VENTRICULAR ASSIST DEVICES MARKET REVENUE BY REGIONS, 2018-2025 (USD MILLION) 45

TABLE 3 OTHER PROMINENT VENDORS OF VENTRICULAR ASSIST DEVICES MARKET 53

TABLE 4 MEDTRONIC PLC: OFFERINGS 54

TABLE 5 MEDTRONIC PLC: RECENT DEVELOPMENTS 54

TABLE 6 ABBOTT LABORATORIES: PRODUCT OFFERINGS 62

TABLE 7 ABBOTT LABORATORIES: RECENT DEVELOPMENTS 62

TABLE 8 RELIANTHEART INC.: OFFERINGS 68

TABLE 9 RELIANTHEART INC.: RECENT DEVELOPMENTS 68

TABLE 10 JARVIK HEART, INC.: PRODUCT OFFERINGS 70

TABLE 11 JARVIK HEART, INC.: RECENT DEVELOPMENTS 70

TABLE 12 BERLIN HEART GMBH: PRODUCT OFFERINGS 72

TABLE 13 BERLIN HEART GMBH: RECENT DEVELOPMENTS 73

TABLE 14 BIVACOR: SNAPSHOT 75

TABLE 15 ABIOMED, INC.: SNAPSHOT 76

TABLE 16 CALON CARDIO-TECHNOLOGY LTD.: SNAPSHOT 78

TABLE 17 MAQUET GMBH (GETINGE AB): SNAPSHOT 79

TABLE 18 LIVANOVA PLC.: SNAPSHOT 80

TABLE 19 EVAHEART MEDICAL USA, INC.: SNAPSHOT 81

TABLE 20 XENIOS AG (FRESENIUS MEDICAL CARE AG & CO. KGAA): SNAPSHOT 82

 

?

Licence Rights

"Single User $3,500- PDF via email with only 1 user license terms or online access with login details to customer
- Multi Users $4,000- PDF via email with up to 10 user license terms
- Enterprise License $5,000- PDF via email, can be utilized across the organization and can upload in their intranet.
We do have the online access for our reports where client can utilize our knowledge store and they will have their login details to access the report online instead of PDF file."

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies


Companies

Medtronic plc

Abbott Laboratories

ReliantHeart Inc.

Berlin Heart GmbH

Jarvik Heart, Inc.

ABIOMED, Inc.

BiVACOR

Calon Cardio-Technology Ltd.

LivaNova PLC

Evaheart Medical USA, Inc. (Asahi Kasei Corp.)

Fresenius Medical Care AG & Co. KGaA (XENIOS AG)

Maquet GmbH (Getinge AB)

Global Ventricular Assist Devices Market 2019-2025

[84 pages report] This market research report includes a detailed segmentation of the global ventricular assist devices market-By Product (Left Ventricular Assist Devices [LVAD], Right Ventricular Assist Devices [RVAD], and Biventricular Assist Devices [BIVAD]), By Design (Transcutaneous Ventricular Assist Devices and Implantable Ventricular Assist Devices), By Application (Bridge-to-Transplant [BTT] Therapy, Destination Therapy, Bridge-to-Recovery [BTR] Therapy, and Bridge-to-Candidacy [BTC] Therapy), and By Region (North America, Europe, Asia Pacific and Rest of the World)

Overview of the Global Ventricular Assist Devices Market Research

Infoholic's market research report predicts that the global ventricular assist devices market will grow at a CAGR of 13.8% during the forecast period. The market has witnessed steady growth in the past few years and development in technology with the introduction of innovative products have increased the acceptance of heart assist devices in the market. The market is fueled by increase in the incidence of heart failure, lack of heart donors for transplantation, and increasing elderly population.

 

 

The market continues to grow and is one of the most widely used devices for the functioning of heart in cardiac failure and weakened heart patients. The market is getting revolutionized with the advancement in technology. Vendors are focusing towards new product launches, product approvals, and targeting towards end-user's perspective. The market generates the revenue from the key players operating in this field and some of vendors are Medtronic plc, Reliant Heart Inc., Abbott Laboratories, Berlin Heart GmbH, Jarvik Heart, Inc., and ABIOMED, Inc.

According to Infoholic Research analysis, North America accounted for the largest share of the global ventricular assist devices market in 2018 and will retain high position during the forecast period. According to American Heart Association, an estimated 92.1 million population in the US have at least one type of CVD and by 2030 it is projected that 43.9% of the US adult population to have some form of CVD. Favorable reimbursement policies, availability of advanced technologies, and growing cardiovascular diseases will increase the adoption and demand of the devices in this region. The Asia Pacific is expected to grow during the forecast period, owing to factors such as high prevalence of cardiovascular diseases, increasing healthcare expenditure, and presence of huge population base.

By Product:

Left Ventricular Assist Devices (LVAD)

Right Ventricular Assist Devices (RVAD)

Biventricular Assist Devices (BIVAD)

In 2018, the left ventricular assist devices segment occupied the largest share and is expected to grow at high CAGR during the forecast period. Increasing number of patients suffering from last-stage heart failure, advancement in technology such as effectiveness, high survival rate, and decreased risk of the devices makes the segment the most common among other VAD devices.

By Design:

Transcutaneous Ventricular Assist Devices

Implantable Ventricular Assist Devices

In 2018, the implantable ventricular assist devices segment occupied the largest share and is expected to grow at high CAGR during the forecast period.

By Application:

Bridge-to-Transplant (BTT) Therapy

Destination Therapy

Bridge-to-Recovery (BTR) Therapy

Bridge-to-Candidacy (BTC) Therapy

By application, the bridge-to-recovery (BTR) therapy generated the maximum revenue, thus accounting for more than 35% of the global ventricular assist devices market in 2018 and the segment is expected to grow at high CAGR during the forecast period. The destination therapy segment is expected to be the second highest growing segment during the forecast period.

By Regions:

North America

Europe

APAC

ROW

The market is dominated by North America, followed by Europe and Asia Pacific. US occupied the major share of the North American market due to the increasing disease prevalence and availability of advanced technologies.

Ventricular Assist Devices Market Research Competitive Analysis-The global ventricular assist devices market has massive growth opportunities in both developed and developing regions. The advancement and upgradation of devices will increase the competition among vendors. Many vendors are focusing on product approvals and developing innovative products to strengthen their product portfolio that intensifies the market competition. In October 2018, FDA approved HeartMate 3 left ventricular assist device developed by Abbott, as a destination therapy for patients with advanced heart failure. The approval device supported by the Momentum 3 trial showed a survival rate of 82.8% at two years with rates of suspected pump thrombosis at only 1.1%. Health Canada issued a Class IV License with conditions to HeartMate 3 left ventricular assist system developed by Thoratec Corporation in 2018. In 2018, Calon Cardio-Technology has launched a clinical trial of the UK's first artificial heart pump. In addition, other leading players are focusing in huge investments on research and development activities to develop new products to attain maximum share in the market.

Key vendors:

Medtronic plc

Abbott Laboratories

ReliantHeart Inc.

Berlin Heart GmbH

Jarvik Heart, Inc.

ABIOMED, Inc.

BiVACOR

Calon Cardio-Technology Ltd.

LivaNova PLC

Evaheart Medical USA, Inc. (Asahi Kasei Corp.)

Fresenius Medical Care AG & Co. KGaA (XENIOS AG)

Maquet GmbH (Getinge AB)

Key competitive facts -

The market is highly competitive with all the players competing to gain market shares. Intense competition, rapid advancements in technology, frequent changes in government policies, and the prices are key factors that confront the market.

The requirement of high initial investment, implementation, and maintenance cost in the market are also limiting the entry of new players.

Benefits-The report provides complete details about the usage and adoption rate of ventricular assist devices. Thus, the key stakeholders can know about the major trends, drivers, investments, vertical player's initiatives, and government initiatives towards the medical devices segment in the upcoming years along with details of the pureplay companies entering the market. Moreover, the report provides details about the major challenges that are going to impact the market growth. Additionally, the report gives complete details about the key business opportunities to key stakeholders in order to expand their business and capture the revenue in specific verticals, and to analyze before investing or expanding the business in this market.

Key Takeaways:

Understanding the potential market opportunity with precise market size and forecast data

Detailed market analysis focusing on the growth of ventricular assist devices industry

Factors influencing the growth of ventricular assist devices market

In-depth competitive analysis of dominant and pureplay vendors

Prediction analysis of ventricular assist devices industry in both developed and developing regions

Key insights related to major segments of the ventricular assist devices market

Latest market trend analysis impacting the buying behavior of the consumers

 

Key Stakeholders -

 

 

READ MORE

Scope

Table of Contents

1 INDUSTRY OUTLOOK 8

1.1 Industry Overview 8

1.1.1 Geography 8

1.1.2 Medical Technologies 8

1.1.3 Industry Trends 10

1.2 Total Addressable Market 11

2 Report Outline 12

2.1 Report Scope 12

2.2 Report Summary 12

2.3 Research Methodology 13

2.4 Report Assumptions 14

3 Market Snapshot 15

3.1 Market Definition-Infoholic Research 15

3.2 Device Benefits 15

3.3 Segmented Addressable Market (SAM) 15

3.4 Trends in the Ventricular Assist Devices Market 16

3.5 Related Markets 17

3.5.1 Stents 17

3.5.2 Interventional Cardiology 17

3.5.3 Angioplasty 17

4 Market Outlook 18

4.1 Regulatory Status 18

4.2 Reimbursement 19

4.3 Market Segmentation 21

4.4 PEST Analysis 21

4.5 Porter 5(Five) Forces 23

5 Market Characteristics 24

5.1 DRO-Global Ventricular Assist Devices Market Dynamics 24

5.1.1 Drivers 25

5.1.1.1 Upsurge in the incidence of cardiovascular disease (CVD) 25

5.1.1.2 Growing geriatric population 25

5.1.1.3 Dearth of heart donors across the globe 26

5.1.2 Opportunities 26

5.1.2.1 Increased approvals, fun ding, and pipeline products 26

5.1.2.2 Upsurge in healthcare spending and demand for better treatment in emerging economies 27

5.1.3 Restraints 27

5.1.3.1 High cost of the devices 27

5.1.3.2 Strict regulatory policies 27

5.2 DRO-Impact Analysis 28

5.3 Key Stakeholders 29

6 Product: Market Size and Analysis 30

6.1 Overview 30

6.2 Left Ventricular Assist Devices 31

6.3 Right Ventricular Assist Devices 32

6.4 Biventricular Assist Devices 33

7 Design: Market Size and Analysis 35

7.1 Overview 35

7.2 Transcutaneous Ventricular Assist Devices 36

7.3 Implantable Ventricular Assist Devices 36

8 Applications: Market Size and Analysis 37

8.1 Overview 37

8.2 Bridge-to-Transplant (BTT) Therapy 38

8.3 Destination Therapy 39

8.4 Bridge-to-Recovery (BTR) Therapy 40

8.5 Bridge-to-Candidacy (BTC) Therapy 41

9 Regions: Market Size and Analysis 43

9.1 Overview 43

9.2 North America 44

9.3 Europe 46

9.4 Asia Pacific 47

9.5 Rest of the World 49

10 Competitive Landscape 51

10.1 Overview 51

11 Vendor Profiles 53

11.1 Medtronic plc 53

11.1.1 Overview 53

11.1.2 Business Units 58

11.1.3 Geographic Presence 59

11.1.4 Business Focus 59

11.1.5 SWOT Analysis 60

11.1.6 Business Strategies 60

11.2 Abbott Laboratories 61

11.2.1 Overview 61

11.2.2 Business Units 64

11.2.3 Geographic Presence 65

11.2.4 Business Focus 65

11.2.5 SWOT Analysis 66

11.2.6 Business Strategies 66

11.3 Reliant Heart Inc. 67

11.3.1 Overview 67

11.3.2 Business Focus 68

11.3.3 SWOT Analysis 68

11.3.4 Business Strategies 68

11.4 Jarvik Heart, Inc. 69

11.4.1 Overview 69

11.4.2 Business Focus 70

11.4.3 SWOT Analysis 70

11.4.4 Business Strategies 71

11.5 Berlin Heart GmbH 71

11.5.1 Overview 71

11.5.2 Business Focus 72

11.5.3 SWOT Analysis 72

11.5.4 Business Strategies 73

12 Companies to Watch For 74

12.1 BiVACOR 74

12.1.1 Overview 74

12.2 ABIOMED, Inc. 74

12.2.1 Overview 74

12.2.2 ABIOMED, Inc.: Recent Developments 75

12.3 Calon Cardio-Technology Ltd. 76

12.3.1 Overview 76

12.3.2 Calon Cardio-Technology Ltd.: Recent Developments 77

12.4 Maquet GmbH (Getinge AB) 77

12.4.1 Overview 77

12.4.2 Maquet GmbH (Getinge AB): Recent Developments 78

12.5 LivaNova PLC 79

12.5.1 Overview 79

12.5.2 LivaNova PLC: Recent Developments 79

12.6 Evaheart Medical USA, Inc. (Asahi Kasei Corp.) 80

12.6.1 Overview 80

12.6.2 Evaheart Medical USA, Inc.: Recent Developments 80

12.7 Fresenius Medical Care AG & Co. KGaA (XENIOS AG) 81

12.7.1 Overview 81

12.7.2 Fresenius Medical Care AG & Co. KGaA (XENIOS AG): Recent Developments 81

13 Annexure 83

13.1 Abbreviations 83

 


List Of Figure

Charts

CHART 1 GLOBAL MEDICAL DEVICES MARKET SEGMENTATION 9

CHART 2 RESEARCH METHODOLOGY OF GLOBAL VENTRICULAR ASSIST DEVICES MARKET 14

CHART 3 GLOBAL VENTRICULAR ASSIST DEVICES MARKET REVENUE, 2018-2025 (USD MILLION) 17

CHART 4 SEGMENTATION OF GLOBAL VENTRICULAR ASSIST DEVICES MARKET 22

CHART 5 PEST ANALYSIS OF GLOBAL VENTRICULAR ASSIST DEVICES MARKET 22

CHART 6 PORTER 5 FORCES ON GLOBAL VENTRICULAR ASSIST DEVICES MARKET 24

CHART 7 MARKET DYNAMICS-DRO ANALYSIS 25

CHART 8 DRO-IMPACT ANALYSIS OF GLOBAL VENTRICULAR ASSIST DEVICES MARKET 29

CHART 9 KEY STAKEHOLDERS OF THE GLOBAL VENTRICULAR ASSIST DEVICES MARKET 30

CHART 10 GLOBAL VENTRICULAR ASSIST DEVICES MARKET BY PRODUCT SEGMENTATION, 2018 (%) 31

CHART 11 GLOBAL VENTRICULAR ASSIST DEVICES MARKET BY TECHNOLOGY SEGMENTATION, 2025 (%) 32

CHART 12 GLOBAL LEFT VENTRICULAR ASSIST DEVICES MARKET FORECAST, 2018-2025 (USD MILLION) 33

CHART 13 GLOBAL RIGHT VENTRICULAR ASSIST DEVICES MARKET FORECAST, 2018-2025 (USD MILLION) 34

CHART 14 GLOBAL BIVENTRICULAR ASSIST DEVICES MARKET FORECAST, 2018-2025 (USD MILLION) 35

CHART 15 GLOBAL VENTRICULAR ASSIST DEVICES MARKET BY DESIGN SEGMENTATION, 2018 (%) 36

CHART 16 GLOBAL VENTRICULAR ASSIST DEVICES MARKET BY APPLICATION SEGMENTATION, 2018 (%) 38

CHART 17 GLOBAL VENTRICULAR ASSIST DEVICES MARKET BY APPLICATION SEGMENTATION, 2025 (%) 39

CHART 18 GLOBAL BRIDGE-TO-TRANSPLANT (BTT) THERAPY MARKET FORECAST, 2018-2025 (USD MILLION) 39

CHART 19 GLOBAL DESTINATION THERAPY MARKET FORECAST, 2018-2025 (USD MILLION) 40

CHART 20 GLOBAL BRIDGE-TO-RECOVERY (BTR) THERAPY MARKET FORECAST, 2018-2025 (USD MILLION) 41

CHART 21 GLOBAL BRIDGE-TO-CANDIDACY (BTC) THERAPY MARKET FORECAST, 2018-2025 (USD MILLION) 42

CHART 22 GLOBAL VENTRICULAR ASSIST DEVICES MARKET BY GEOGRAPHICAL SEGMENTATION, 2018 (%) 44

CHART 23 GLOBAL VENTRICULAR ASSIST DEVICES MARKET BY GEOGRAPHICAL SEGMENTATION, 2025 (%) 45

CHART 24 VENTRICULAR ASSIST DEVICES MARKET REVENUE IN NORTH AMERICA, 2018-2025 (USD MILLION) 46

CHART 25 VENTRICULAR ASSIST DEVICES MARKET REVENUE IN EUROPE, 2018-2025 (USD MILLION) 48

CHART 26 VENTRICULAR ASSIST DEVICES MARKET REVENUE IN ASIA PACIFIC, 2018-2025 (USD MILLION) 49

CHART 27 VENTRICULAR ASSIST DEVICES MARKET REVENUE IN REST OF THE WORLD, 2018-2025 (USD MILLION) 51

CHART 28 MEDTRONIC PLC: OVERVIEW SNAPSHOT 57

CHART 29 MEDTRONIC PLC: BUSINESS UNITS 59

CHART 30 MEDTRONIC PLC: GEOGRAPHIC PRESENCE 60

CHART 31 MEDTRONIC PLC: SWOT ANALYSIS 61

CHART 32 ABBOTT LABORATORIES: OVERVIEW SNAPSHOT 64

CHART 33 ABBOTT LABORATORIES: BUSINESS UNITS 65

CHART 34 ABBOTT LABORATORIES: GEOGRAPHIC PRESENCE 66

CHART 35 ABBOTT LABORATORIES: SWOT ANALYSIS 67

CHART 36 RELIANTHEART INC.: SWOT ANALYSIS 69

CHART 37 JARVIK HEART, INC.: SWOT ANALYSIS 71

CHART 38 BERLIN HEART GMBH: SWOT ANALYSIS 73

 

 

 


List Of Table

TABLE 1 REGULATORY STATUS OF GLOBAL VENTRICULAR ASSIST DEVICES MARKET 19

TABLE 2 GLOBAL VENTRICULAR ASSIST DEVICES MARKET REVENUE BY REGIONS, 2018-2025 (USD MILLION) 45

TABLE 3 OTHER PROMINENT VENDORS OF VENTRICULAR ASSIST DEVICES MARKET 53

TABLE 4 MEDTRONIC PLC: OFFERINGS 54

TABLE 5 MEDTRONIC PLC: RECENT DEVELOPMENTS 54

TABLE 6 ABBOTT LABORATORIES: PRODUCT OFFERINGS 62

TABLE 7 ABBOTT LABORATORIES: RECENT DEVELOPMENTS 62

TABLE 8 RELIANTHEART INC.: OFFERINGS 68

TABLE 9 RELIANTHEART INC.: RECENT DEVELOPMENTS 68

TABLE 10 JARVIK HEART, INC.: PRODUCT OFFERINGS 70

TABLE 11 JARVIK HEART, INC.: RECENT DEVELOPMENTS 70

TABLE 12 BERLIN HEART GMBH: PRODUCT OFFERINGS 72

TABLE 13 BERLIN HEART GMBH: RECENT DEVELOPMENTS 73

TABLE 14 BIVACOR: SNAPSHOT 75

TABLE 15 ABIOMED, INC.: SNAPSHOT 76

TABLE 16 CALON CARDIO-TECHNOLOGY LTD.: SNAPSHOT 78

TABLE 17 MAQUET GMBH (GETINGE AB): SNAPSHOT 79

TABLE 18 LIVANOVA PLC.: SNAPSHOT 80

TABLE 19 EVAHEART MEDICAL USA, INC.: SNAPSHOT 81

TABLE 20 XENIOS AG (FRESENIUS MEDICAL CARE AG & CO. KGAA): SNAPSHOT 82

 

?

"Single User $3,500- PDF via email with only 1 user license terms or online access with login details to customer
- Multi Users $4,000- PDF via email with up to 10 user license terms
- Enterprise License $5,000- PDF via email, can be utilized across the organization and can upload in their intranet.
We do have the online access for our reports where client can utilize our knowledge store and they will have their login details to access the report online instead of PDF file."

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Companies

Medtronic plc

Abbott Laboratories

ReliantHeart Inc.

Berlin Heart GmbH

Jarvik Heart, Inc.

ABIOMED, Inc.

BiVACOR

Calon Cardio-Technology Ltd.

LivaNova PLC

Evaheart Medical USA, Inc. (Asahi Kasei Corp.)

Fresenius Medical Care AG & Co. KGaA (XENIOS AG)

Maquet GmbH (Getinge AB)

chat_bubbleLet's Chat